These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 30715361)
1. New Vaccine Design and Delivery Technologies. Kanekiyo M; Ellis D; King NP J Infect Dis; 2019 Apr; 219(Suppl_1):S88-S96. PubMed ID: 30715361 [TBL] [Abstract][Full Text] [Related]
2. Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins. Ross TM J Infect Dis; 2019 Apr; 219(Suppl_1):S57-S61. PubMed ID: 30715379 [TBL] [Abstract][Full Text] [Related]
3. Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain. Krammer F; Palese P J Infect Dis; 2019 Apr; 219(Suppl_1):S62-S67. PubMed ID: 30715353 [TBL] [Abstract][Full Text] [Related]
4. Progress in the Development of Universal Influenza Vaccines. Sun W; Luo T; Liu W; Li J Viruses; 2020 Sep; 12(9):. PubMed ID: 32957468 [TBL] [Abstract][Full Text] [Related]
5. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
6. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses. Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350 [TBL] [Abstract][Full Text] [Related]
7. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine. Cho A; Wrammert J Curr Opin Virol; 2016 Apr; 17():110-115. PubMed ID: 27031684 [TBL] [Abstract][Full Text] [Related]
9. Development of next generation hemagglutinin-based broadly protective influenza virus vaccines. Nachbagauer R; Palese P Curr Opin Immunol; 2018 Aug; 53():51-57. PubMed ID: 29680576 [TBL] [Abstract][Full Text] [Related]
10. Stalking influenza diversity with a universal antibody. Russell CJ N Engl J Med; 2011 Oct; 365(16):1541-2. PubMed ID: 22010922 [No Abstract] [Full Text] [Related]
11. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789 [TBL] [Abstract][Full Text] [Related]
12. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza. Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687 [TBL] [Abstract][Full Text] [Related]
13. Universal influenza vaccines, a dream to be realized soon. Zhang H; Wang L; Compans RW; Wang BZ Viruses; 2014 Apr; 6(5):1974-91. PubMed ID: 24784572 [TBL] [Abstract][Full Text] [Related]